Adrian Parkinson

Articles by Adrian Parkinson

Quality by Design for analytical methods for use with orally inhaled and nasal drug products

ByAndrew Crumpton,Adrian Parkinson,Holger Memmesheimer,Svetlana Lyapustina,Kevin Hawkins,David Christopher,Sebastian Kaerger,Bruce Wyka,Andy Rignall,Mary Ann Smith

October 1st 2008

Pharmaceutical Technology Europe

The design of accurate and robust analytical methodology is instrumental to developing orally inhaled and nasal drug products (OINDPs) and their appropriate control programmes.

Latest Updated Articles

Quality by Design for analytical methods for use with orally inhaled and nasal drug products
October 1st 2008

Adrian Parkinson

Articles by Adrian Parkinson

Quality by Design for analytical methods for use with orally inhaled and nasal drug products

Latest Updated Articles

Trending on Pharmaceutical Technology

Regulatory Roundup—July 2026

Seventeen Peptide Guidance Revised: What Developers Need to Know

Quality and Regulations eBook July 2026

GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy

PharmTech Weekly Roundup—July 31, 2026